Intervention Review

Antibiotics for exacerbations of chronic obstructive pulmonary disease

  1. Daniela J Vollenweider1,*,
  2. Harish Jarrett2,
  3. Claudia A Steurer-Stey3,
  4. Judith Garcia-Aymerich4,5,6,7,
  5. Milo A Puhan8

Editorial Group: Cochrane Airways Group

Published Online: 12 DEC 2012

Assessed as up-to-date: 13 SEP 2012

DOI: 10.1002/14651858.CD010257


How to Cite

Vollenweider DJ, Jarrett H, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD010257. DOI: 10.1002/14651858.CD010257.

Author Information

  1. 1

    John Hopkins University, General Internal Medicine, Baltimore, MD, USA

  2. 2

    Temple University Hospital, Department of Internal Medicine, Philadelphia, USA

  3. 3

    University of Zurich, Institute of General Practice, Zurich, Switzerland

  4. 4

    Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain

  5. 5

    Hospital del Mar Research Institute (IMIM), Barcelona, Spain

  6. 6

    CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain

  7. 7

    University of Pompeu Fabra, Department of Experimental and Health Sciences, Barcelona, Spain

  8. 8

    Johns Hopkins Bloomberg School of Public Health, Epidemiology, Baltimore, MD, USA

*Daniela J Vollenweider, General Internal Medicine, John Hopkins University, Baltimore, MD, 21287, USA. danivollenweider@yahoo.de. dpuhanv1@jhmi.edu.

Publication History

  1. Publication Status: New
  2. Published Online: 12 DEC 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    María Montes de Oca, María Victorina López Varela, Agustín Acuña, Eduardo Schiavi, María Alejandra Rey, José Jardim, Alejandro Casas, Antonio Tokumoto, Carlos A. Torres Duque, Alejandra Ramírez-Venegas, Gabriel García, Roberto Stirbulov, Aquiles Camelier, Miguel Bergna, Mark Cohen, Santiago Guzmán, Efraín Sánchez, ALAT-2014 Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice Guidelines: Questions and Answers, Archivos de Bronconeumología (English Edition), 2015, 51, 8, 403

    CrossRef

  2. 2
    David F Strykowski, Anni B S Nielsen, Carl Llor, Volkert Siersma, Lars Bjerrum, An intervention with access to C-reactive protein rapid test reduces antibiotic overprescribing in acute exacerbations of chronic bronchitis and COPD, Family Practice, 2015, cmv020

    CrossRef

  3. 3
    Mustafa Dogan, Levent Cem Mutlu, İbrahim Yilmaz, Bulent Bilir, Gamze Varol Saracoglu, Aliye Yildirim Guzelant, Are treatment guides and rational drug use policies adequately exploited in combating respiratory system diseases?, Journal of Infection and Public Health, 2015,

    CrossRef

  4. 4
    María Montes de Oca, María Victorina López Varela, Agustín Acuña, Eduardo Schiavi, María Alejandra Rey, José Jardim, Alejandro Casas, Antonio Tokumoto, Carlos A. Torres Duque, Alejandra Ramírez-Venegas, Gabriel García, Roberto Stirbulov, Aquiles Camelier, Miguel Bergna, Mark Cohen, Santiago Guzmán, Efraín Sánchez, Guía de práctica clínica de la enfermedad pulmonar obstructiva crónica (EPOC) ALAT-2014: Preguntas y respuestas, Archivos de Bronconeumología, 2015, 51, 8, 403

    CrossRef

  5. 5
    Jose Luis Lopez-Campos, Alvar Agustí, Heterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposal, The Lancet Respiratory Medicine, 2015,

    CrossRef

  6. 6
    Rachel H. Bardowell, Robert J. Mahoney, Wheezing, Hospital Medicine Clinics, 2015, 4, 3, 297

    CrossRef

  7. 7
    G. Deslée, Bronchopneumopathie chronique obstructive, Revue des Maladies Respiratoires Actualités, 2014, 6, 4, 16

    CrossRef

  8. 8
    Natasha Gunawardana, Lydia Finney, Sebastian L. Johnston, Patrick Mallia, Experimental rhinovirus infection in COPD: Implications for antiviral therapies, Antiviral Research, 2014, 102, 95

    CrossRef

  9. 9
    Robert P Dickson, Fernando J Martinez, Gary B Huffnagle, The role of the microbiome in exacerbations of chronic lung diseases, The Lancet, 2014, 384, 9944, 691

    CrossRef

  10. 10
    Hasan M. Al-Dorzi, Raymond Khan, Yaseen M. Arabi, Life-threatening Infections in Medically Immunocompromised Patients, Critical Care Clinics, 2013, 29, 4, 807

    CrossRef

  11. 11
    Adarsh Gupta, What are the benefits and harms of antibiotics in outpatients with exacerbations of chronic obstructive pulmonary disease?, Cochrane Clinical Answers,
  12. 12
    Adarsh Gupta, What are the benefits and harms of antibiotics in people attending the intensive care unit or admitted to hospital with exacerbations of chronic obstructive pulmonary disease?, Cochrane Clinical Answers,